BRAF and thyroid gland carcinoma: Our analysis also uncovered that BRAF V600E mutation in thyroid cancer (THCA) creates an immune suppressive tumor microenvironment by increasing Treg, neutrophil, and monocyte infiltration, while decreasing the infiltration of NK cells and CD4+ T-cells.